Eine Kamera ist auf eine reflektierende Glasscheibe gerichtet.
© DZIF

News

All current DZIF news can be found here.

multidrug-resistant E. coli bacteria
© JLU/Katrina Friese

A new antibiotic to combat drug-resistant bacteria is in sight

An international team of researchers, with the participation of Giessen University and the German Center for Infection Research (DZIF), discovered a new active substance effective against gram

Working together to develop strategies against infectious diseases

We previously thought we had conquered infectious diseases. Now they are once again one of the most common causes of death all over the world. It has since become clear that the increase in antibiotic

Masernvirus
© cdc/ Goldsmith and Bellini

Measles infections erase immunological memory – measles vaccination confers protection

Measles infections are not harmless – they can cause disease courses that may be of fatal outcome. Researchers of the Paul-Ehrlich-Institut (PEI) in co-operation with researchers from the UK and the

Florian Klein (li) und Team
© Uniklinik Köln/Dorothea Hensen

Researchers decode the immune response to Ebola vaccine

The vaccine rVSV-EBOV is currently used in the fight against Ebola virus. Since 2018, more than 200,000 people have been vaccinated. However, how the vaccine actually works was only partially known

Listeriose-pathogen
© S. Doijad, L. La Pietra

Highly virulent Listeriosis pathogen discovered

An international team of researchers identifies the genetic basis for the hypervirulence of a Listeria strain that can cause severe infections. The work was coordinated by scientists at the Justus

Pseudomonas aeruginosa
© CDC/James Archer

Could green tea hold the key to reducing antibiotic resistance?

Since the early ages green tea has been known for its numerous health benefits. A recent study goes further and shows that it also could help to fight antibiotic resistant bacteria. DZIF scientists at

Spitzmaus
© Ulrike Rosenfeld

Hepatitis B: Unusual virus discovered in shrews

The discovery of an unusual hepatitis B virus from shrews offers new opportunities of better understanding the chronic progression of the disease. International research teams were able to demonstrate

Dirk Busch and his study team
© K. Schober/TUM

Successful T cell engineering with gene scissors

The idea of genetically modifying a patient’s own immune cells and deploying them against infections and tumors has been around since the 1980s. But to this day modified T cells are still not as

Staphylococcus aureus (magenta-colored)
© NIAID

Natural antibiotic’s multi-level attack strategy helps prevent resistance

The natural antibiotic Lugdunin, discovered three years ago by Tübingen DZIF researchers, attacks pathogenic bacteria in several different ways simultaneously and also interacts with the defense

Hepatitis B virions (orange coloured)
© CDC/Dr. Erskine Palmer

Checkmate for hepatitis B viruses in the liver

Researchers have for the first time succeeded in conquering a chronic infection with the hepatitis B virus in a mouse model. The team showed in its publication, that T-cell therapy can provide a